March 2012

Applying Clinical Data to Practice in AMD

Allen C. Ho, MD Chief Medical Editor and Robert L. Avery, MD Associate Medical Editor

The Sunshine Act's Intimidation Factor

Will the noble objectives of this law set up a roadblock to innovation?

Richard S. Kaiser, MD, and Jonathan L. Prenner, MD

Meaningful Use of EHR

Meaningful use must be demonstrated to earn Medicare incentive payments.

Jeremy D. Wolfe, MD

Translating Clinical Trial Results to Practice

David Boyer, MD; Matthew Benz, MD; and Alexander Eaton, MD

Turning Ideas Into Products

Part 2 of 2 parts. Dealing with companies and taking your idea to market.

Nikolas J.S. London, MD; Andre J. Witkin, MD; and Alok S. Bansal, MD with Emmett T. Cunningham Jr., MD, PHD, MPH; Paul E. Tornambe, MD; and Eugene De Juan Jr., MD

Single-point Scleral Fixation of a Decentered IOL Without Vitrectomy

A minimally invasive, straightforward rescue technique.

Nicole Siegel, MD; Steven Ness, MD; and Vasiliki Poulaki, MD, PHD

Treatment of Polypoidal Choroidal Vasculopathy

Individualized plans may be warranted, as the disease course can vary.

Won Ki Lee, MD

Extreme Buckling

John W. Kitchens, MD

Choroidal Melanoma With Retinal Invasion

Timothy V, Johnson, MD; Swathi Kaliki, MD; and Carol L. Shields, MD

Intravitreal Aflibercept for AMD: 2-year Results

The VIEW 1 and 2 studies showed high degrees of safety and efficacy at 2 years.

Jeffery S. Heier, MD

My Use of Aflibercept in Clinical Practice

Philip J. Rosenfeld, MD, PHD

The Consequences of CATT

How the study results have affected my treatment approach for AMD.

Rohit Ross Lakhanpal, MD, FACS

AMD and Imaging: 2 Articles

Glenn J. Jaffe, MD and James D. Palmer, MD

Radiation Treatments for Neovascular AMD

Pravin U. Dugel, MD

Steroid Implant Alone and as an Adjunct to Anti-VEGF for CNV in AMD

The extended-release device alone provided clinically and statistically significant improvement in central retinal thickness.

Michael A. Singer, MD

Neuroprotection in Age-related Macular Degeneration

Preventing apoptosis may not be enough to prevent cell death.

Demetrios G. Vavvas, MD, PHD

Dietary Supplements as Adjuncts in Combination Therapy for AMD

A new study suggests that nutritional supplements may have the potenial to enhance the effect of anti-VEGF agents plus photodynamic therapy or laser.

R. Joseph Olk, MD

Combination Therapy for Diffuse DME

Keith A. Warren, MD

Treatment of Retinal Vein Occlusion

Individualized therapy is crucial to good patient outcomes.

Gaurav K. Shah, MD

5 Questions With Carl D. Regillo, MD